MILTON KEYNES, UK, 29 November 2024 – MSD Animal Health’s early life intranasal calf pneumonia vaccine Bovilis® INtranasal RSP™ Live is now available in 20-dose vials for improved administration flexibility.
The intranasal vaccine can be administered to calves from the day of birth onwards and reduces the clinical signs of respiratory disease and viral shedding from infection with Bovine Respiratory Syncytial Virus (BRSV) and Parainfluenza-3 Virus (Pi3V). No other UK-licensed BRD vaccine can be administered earlier in life. The vaccine also delivers the fastest on-farm protection, with an onset of immunity after administration from the day of birth onwards of six days for BRSV (five days for calves vaccinated from the age of one week onwards) and seven days for Pi3V. Duration of immunity is 12 weeks for both viruses.
“Having this early life calf pneumonia vaccine available in 20-dose vials will give farmers added flexilbility when vaccinating batches of calves around the same time. We know that early-age protection of young calves through intranasal vaccination can help prevent pneumonia and positively impact a beef or dairy calf’s productive future,” says MSD Animal Health livestock veterinary adviser Dr Kat Baxter-Smith.
The new 20-dose vials complement the single and five dose vials already available. Vets interested in further information about this early life calf pneumonia vaccine should contact their MSD account manager for details.
Leave a Reply